Loading…
RxSight, Inc. is projected to rise to $6.39 by 2027, a +14% move from its current price of $5.62. RXST is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.43 | $5.62 | $5.82 | +0.05% |
| May 30 | $5.35 | $5.63 | $5.91 | +0.10% |
| May 31 | $5.30 | $5.63 | $5.98 | +0.15% |
| Jun 1 | $5.25 | $5.63 | $6.04 | +0.20% |
| Jun 2 | $5.21 | $5.63 | $6.09 | +0.25% |
| Jun 3 | $5.17 | $5.64 | $6.14 | +0.30% |
| Jun 4 | $5.14 | $5.64 | $6.19 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.14 | $5.64 | $6.19 | +0.35% |
| Week 2 | $4.96 | $5.66 | $6.45 | +0.69% |
| Week 3 | $4.83 | $5.68 | $6.67 | +1.04% |
| Week 4 | $4.73 | $5.70 | $6.86 | +1.39% |
| Week 5 | $4.64 | $5.72 | $7.04 | +1.74% |
| Week 6 | $4.57 | $5.74 | $7.21 | +2.09% |
| Week 7 | $4.50 | $5.76 | $7.36 | +2.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
RxSight, Inc. is a commercial-stage medical technology company in the Healthcare sector that engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.
Its RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.
RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
RxSight is trading at $5.62 with a market capitalization of $232.65M. It ranks 3694 by market cap.
The near-term technical picture shows a neutral stance, with a 30-day range from $4.46 to $7.09 and a key support at $5.52 and resistance at $7.61.
The RSI(14) is 40, while the moving averages stand at SMA50 of $6.64 and SMA200 of $8.64. The stock also exhibits higher annualized volatility, listed at 70%.
The long-range forecast projects a path from a flat to modestly rising near-term trend into a stronger uptrend later, with multi-year milestones indicating bullish sentiment starting in the 2030s and notable upside by 2040 and beyond.
A major floor 26.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 35.4% above — a clean break opens room to run.
A major ceiling 77.0% above — clearing it would confirm fresh momentum.
Key RXST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RXST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.04 | Sell | $5.91 | Sell |
| MA 10 | $5.90 | Sell | $5.99 | Sell |
| MA 20 | $6.23 | Sell | $6.20 | Sell |
| MA 50 | $6.64 | Sell | $6.75 | Sell |
| MA 100 | $7.66 | Sell | $7.59 | Sell |
| MA 200 | $8.64 | Sell | $10.07 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.11 | Neutral |
| Stoch RSI (14) | 37.71 | Neutral |
| CCI (20) | -74.59 | Neutral |
| Williams %R (14) | -87.95 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -3.93 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 12.05 | Buy |
| TRIX (15) | -0.64 | Sell |
| Awesome (5,34) | -0.59 | Sell |
| Ultimate (7,14,28) | 41.30 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 6.02 | Sell |
| ADX (14) | 18.46 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is Neutral.
RSI(14) is 40. The SMA50 is $6.64 and the SMA200 is $8.64.
The 30-day range runs from $4.46 to $7.09, with support at $5.52 and resistance at $7.61.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.52 | $5.62 | $7.53 | 0% | Neutral | |
| $4.93 | $6.39 | $8.86 | +14% | Neutral | |
| $4.72 | $6.35 | $9.19 | +13% | Neutral | |
| $3.86 | $5.36 | $8.04 | -5% | Neutral | |
| $4.09 | $5.82 | $8.99 | +4% | Neutral | |
| $4.58 | $6.69 | $10.59 | +19% | Neutral | |
| $4.95 | $7.40 | $12.00 | +32% | Bullish | |
| $5.21 | $7.96 | $13.17 | +42% | Bullish | |
| $4.85 | $7.58 | $12.77 | +35% | Bullish | |
| $4.68 | $7.46 | $12.80 | +33% | Bullish | |
| $5.88 | $10.31 | $19.02 | +84% | Bullish | |
| $8.92 | $18.52 | $37.95 | +230% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.52 | $5.62 | $6.62 | +0.00% |
| June 2026 | $4.86 | $5.75 | $6.98 | +2.24% |
| July 2026 | $4.92 | $5.88 | $7.26 | +2.30% |
| August 2026 | $4.71 | $5.67 | $7.10 | -3.47% |
| September 2026 | $4.58 | $5.56 | $7.03 | -2.02% |
| October 2026 | $4.72 | $5.77 | $7.37 | +3.81% |
| November 2026 | $4.77 | $5.87 | $7.56 | +1.63% |
| December 2026 | $4.69 | $5.80 | $7.53 | -1.17% |
Click any year to see its month-by-month RXST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RXST is projected to trade between $5.52 and $7.53, averaging $5.62 — a potential gain of 0% from today's $5.62. Price action looks broadly range-bound.
RxSight, Inc.'s 2027 outlook centres on $6.39, within a $4.93 to $8.86 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, RXST could reach as high as $9.19, with a base case around $6.35 and support toward $4.72 — roughly +13% from $5.62. Price action looks broadly range-bound.
Expect RXST to range from $3.86 to $8.04 through 2029. The $5.36 average target implies a -5% move from current prices. That is -16% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The RXST price prediction for 2030 points to an average of $5.82 (low $4.09, high $8.99) — a potential gain of +4% on today's $5.62. Price action looks broadly range-bound.
In 2031, RXST is projected to trade between $4.58 and $10.59, averaging $6.69 — a potential gain of +19% from today's $5.62. That is up +15% on the projected 2030 average. A consolidation phase looks the most probable path here.
RxSight, Inc.'s 2032 outlook centres on $7.40, within a $4.95 to $12.00 range. That is up +11% on the projected 2031 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2033, RXST could reach as high as $13.17, with a base case around $7.96 and support toward $5.21 — roughly +42% from $5.62. Buyers look set to stay in control over this stretch.
Expect RXST to range from $4.85 to $12.77 through 2034. The $7.58 average target implies a +35% move from current prices. That is -5% versus the projected 2033 average. Momentum favours further upside here.
The RXST price prediction for 2035 points to an average of $7.46 (low $4.68, high $12.80) — a potential gain of +33% on today's $5.62. Buyers look set to stay in control over this stretch.
In 2040, RXST is projected to trade between $5.88 and $19.02, averaging $10.31 — a potential gain of +84% from today's $5.62. That is up +38% on the projected 2035 average. Momentum favours further upside here.
RxSight, Inc.'s 2050 outlook centres on $18.52, within a $8.92 to $37.95 range. That is up +80% on the projected 2040 average. That marks a +230% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in RXST today (≈ 177.935943 RXST) could be worth
$3,296.21
+$2,296.21 (+230%) by 2050 · US Dollar
Based on the average projected RXST price of $18.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RXSTwould be worth at today's price.
$1,000 invested in RXST on May 27, 2025 (≈ 62.460961 RXST) would be worth
$351.03
-$648.97 (-64.9%) today · 0.35× · US Dollar
Based on a RXST entry price of $16.01 vs. today's $5.62.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.16 | $912.34 | -8.8% |
| 1 month ago | $7.29 | $770.92 | -22.9% |
| 3 months ago | $7.92 | $709.6 | -29.0% |
| 6 months ago | $11.42 | $492.12 | -50.8% |
| 1 year ago | $16.01 | $351.03 | -64.9% |
| All time (4.8y) ago | $16 | $351.25 | -64.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RXST forecast.
Our base-case forecast reaches $11.00 around 2050.
Implied market cap at $11.00: $455.36M
The 2026 forecast shows min $5.52, avg $5.62, max $7.53 with ROI 0 and sentiment NEUTRAL.
The 2027 forecast shows min $4.93, avg $6.39, max $8.86 with ROI 13.8 and sentiment NEUTRAL.
The 2028 forecast shows min $4.72, avg $6.35, max $9.19 with ROI 12.9 and sentiment NEUTRAL.
The 2029 forecast shows min $3.86, avg $5.36, max $8.04 with ROI -4.7 and sentiment NEUTRAL.
The 2030 forecast shows min $4.09, avg $5.82, max $8.99 with ROI 3.5 and sentiment NEUTRAL.
The 2031 forecast shows min $4.58, avg $6.69, max $10.59 with ROI 19 and sentiment NEUTRAL.
The 2032 forecast shows min $4.95, avg $7.40, max $12.00 with ROI 31.8 and sentiment BULLISH.
The 2033 forecast shows min $5.21, avg $7.96, max $13.17 with ROI 41.7 and sentiment BULLISH.
The 2034 forecast shows min $4.85, avg $7.58, max $12.77 with ROI 34.9 and sentiment BULLISH.
The 2035 forecast shows min $4.68, avg $7.46, max $12.80 with ROI 32.8 and sentiment BULLISH.
The 2040 forecast shows min $5.88, avg $10.31, max $19.02 with ROI 83.5 and sentiment BULLISH.
The 2050 forecast shows min $8.92, avg $18.52, max $37.95 with ROI 229.6 and sentiment BULLISH.
Tap a question to reveal the answer.
In 2030 the forecast shows min $4.09, avg $5.82, max $8.99 with ROI 3.5 and sentiment NEUTRAL.
The forecast contains years with positive ROI (e.g., 2027 ROI 13.8, 2032 ROI 31.8, 2033 ROI 41.7, 2040 ROI 83.5, 2050 ROI 229.6) and years with negative ROI (2029 ROI -4.7). This indicates mixed outcomes and uncertainty.
Yes. The 2032-2033 period shows max values of $12.00 and $13.17, respectively, indicating potential to exceed $10 in that window.
The 2040 forecast lists min $5.88, avg $10.31, max $19.02 with ROI 83.5 and sentiment BULLISH.
The current price is $5.62 and the market capitalization is $232.65M.
RxSight, Inc. Community Discussion
0Share your RxSight, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.